J. Joseph

Blockade of VLA4 sensitizes leukemic and myeloma tumor cells to CD3 redirection in the bone marrow microenvironment

K. Packman, Melissa E. Smith, L. Luistro, 2020, Blood Cancer Journal.

A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemia.

Gerald C. Chu, G. Chu, K. Packman, 2020, Blood advances.

A T CELL REDIRECTING BISPECIFIC G-PROTEIN COUPLED RECEPTOR CLASS 5 MEMBER DxCD3 ANTIBODY TO TREAT MULTIPLE MYELOMA.

Gerald C. Chu, G. Chu, S. Edavettal, 2020, Blood.

B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma.

Weiss, Iulian Pruteanu-Malinici, B. Levine, 2019, The Journal of clinical investigation.